Found: 16
Select item for more details and to access through your institution.
The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 4, p. 1267, doi. 10.1007/s13402-024-00926-w
- By:
- Publication type:
- Article
The expressed mutational landscape of microsatellite stable colorectal cancers.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00955-2
- By:
- Publication type:
- Article
Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 5, p. 811, doi. 10.1007/s10120-020-01064-6
- By:
- Publication type:
- Article
Prognostic significance of β-catenin, E-cadherin, and SOX9 in colorectal cancer: results from a large population-representative series.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00118
- By:
- Publication type:
- Article
E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 12, p. 2312, doi. 10.1002/1878-0261.13159
- By:
- Publication type:
- Article
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 9, p. 1639, doi. 10.1002/1878-0261.12347
- By:
- Publication type:
- Article
Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 9, p. 1156, doi. 10.1002/1878-0261.12086
- By:
- Publication type:
- Article
Multispectral imaging for quantitative and compartment‐specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients.
- Published in:
- Journal of Pathology, 2018, v. 244, n. 4, p. 421, doi. 10.1002/path.5026
- By:
- Publication type:
- Article
Antibody crossreactivity between the tumour suppressor PHLPP1 and the proto-oncogene β-catenin.
- Published in:
- EMBO Reports, 2013, v. 14, n. 1, p. 10, doi. 10.1038/embor.2012.188
- By:
- Publication type:
- Article
Connexins in colorectal cancer pathogenesis.
- Published in:
- International Journal of Cancer, 2015, v. 137, n. 1, p. 1, doi. 10.1002/ijc.28911
- By:
- Publication type:
- Article
A novel transcript, VNN1-AB, as a biomarker for colorectal cancer.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 9, p. 2077, doi. 10.1002/ijc.28855
- By:
- Publication type:
- Article
Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 3, p. 570, doi. 10.1002/ijc.26392
- By:
- Publication type:
- Article
Correction: Tumour-infiltrating CD8<sup>+</sup> lymphocytes and colorectal cancer recurrence by tumour and nodal stage.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Tumour-infiltrating CD8<sup>+</sup> lymphocytes and colorectal cancer recurrence by tumour and nodal stage.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies.
- Published in:
- Molecular Cancer, 2017, v. 16, p. 1, doi. 10.1186/s12943-017-0691-y
- By:
- Publication type:
- Article